BridgeBio Pharma stock supported by Raymond James after $300M royalty deal – RP Digital

Business

BridgeBio Pharma stock supported by Raymond James after $300M royalty deal

June 30, 20251 min0

BridgeBio Pharma stock supported by Raymond James after $300M royalty deal

Source link

rpdigital

Leave a Reply Cancel reply

Related Articles

BancFirst declares quarterly dividend and trust interest payment

rpdigitalAugust 28, 20250

Jefferies raises Ollie's Bargain Outlet stock price target to $135 on strong growth

rpdigitalAugust 28, 20250